Valuation IMPACT Therapeutics, Inc

Stocks

Market Closed - Hong Kong S.E. 11:08:27 30/09/2026 +03			5-day change	1st Jan Change
14.07 ^HKD	+1.01%		-12.83%	-

09-18	IMPACT Therapeutics And Pharmanovia Receive Positive CHMP Opinion For Senaparib As First-Line Maintenance Treatment Of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, And Primary Peritoneal Cancer	CI
09-18	Impact Therapeutics Gets Positive EMA Opinion for Ovarian Cancer Drug	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2026	2027	2028
Market Cap ¹	3,397	-	-
Change	-	-	-
Enterprise Value (EV) ¹	2,581	2,392	2,269
Change	-	-7.33%	-5.13%
P/E	-	-	-
PBR	-	-	-
PEG	-	-	-
Capitalization / Revenue	12.8x	5.4x	4.91x
EV / Revenue	9.75x	3.8x	3.28x
EV / EBITDA	-18.3x	19.7x	35.6x
EV / EBIT	-17.9x	20.2x	37.8x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-	-	-
Distribution rate	-	-	-
Net sales ¹	264.8	629.6	692
EBITDA ¹	-140.7	121.4	63.66
EBIT ¹	-144.2	118.4	59.97
Net income	-	-	-
Net Debt ¹	-816.4	-1,006	-1,128
Reference price ²	12.03	12.03	12.03
Nbr of stocks (in thousands)	282,462	-	-
Announcement Date	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
IMPACT THERAPEUTICS, INC	-	11.78x	-22.16x	-	501M
WUXI APPTEC CO., LTD.	20.87x	7.45x	14.96x	1.42%	71.53B
ARGENX SE	31.24x	9x	28.05x	0.04%	60.12B
LONZA GROUP AG	34.13x	6.11x	18.31x	0.95%	48.85B
IQVIA HOLDINGS INC.	34.64x	3.34x	14.41x	-.--%	44.28B
REVOLUTION MEDICINES, INC.	-21.08x	228.26x	-22.72x	-.--%	43.83B
BEONE MEDICINES AG	47.85x	5.53x	30.37x	-.--%	41.53B
CELLTRION, INC.	27.07x	7.8x	20.09x	0.42%	30.13B
WUXI BIOLOGICS (CAYMAN) INC.	32.39x	6.91x	17.94x	-.--%	27.98B
INSMED INCORPORATED	-70.94x	13.62x	-69.42x	-.--%	25.25B
Average	15.13x	29.98x	2.98x	0.32%	39.4B
Weighted average by Cap.	19.23x	31.81x	9.89x	0.42%